Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: A possible correlation with altered adaptive immune responsiveness in HHT

Current Pharmaceutical Design

Volumn 12, Issue 10, 2006, Pages 1209-1215

  Cirulli, Anna ^a   Loria, Maria Paola ^a   Dambra, Porzia ^a   Di Serio, Francesca ^b   Ventura, Maria T ^a   Amati, Luigi ^c   Jirillo, Emilio ^a,c   Sabbà, Carlo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

^c Sci Institute of Gastroenterology   (Italy)

Author keywords

HHT; Innate immunity; Rendu Osler Weber disease

Indexed keywords

IMMUNOGLOBULIN; MONOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; INDIVIDUALITY; INFECTION; INNATE IMMUNITY; MALE; MONOCYTE; NATURAL KILLER CELL; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; RESPIRATORY BURST; T LYMPHOCYTE; TH1 CELL; AGED; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEUTROPHIL; PHENOTYPE; PHYSIOLOGY; REPRODUCIBILITY;

ADULT; AGED; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; PHENOTYPE; REPRODUCIBILITY OF RESULTS; RESPIRATORY BURST; T-LYMPHOCYTES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 33744999896     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206776361336     Document Type: Article

References (29)

1. Kjelden AD, Vase P, Green A. Hereditary Hemorrhagic Telangiectasia, HHT. A population based study of prevalence and mortality in Danish HHT patients. J Int Med 1991; 245: 31-41.
2. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe, et al. Genetic epidemiology of Hereditary Hemorrhagic Telangiectasia in a local community in the northern part of Japan. Hum Mutation 2002; 19: 140-8.
3. Guttmacher AE, Marchuk DA, White RJ. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333: 918-24.
4. Mc Allister KA, Grogg KM, Johnson D Wetal. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia, type I. Nat Genet 1994; 8: 345-51.
5. Shovlin CL, Hughes JMB, Tuddenham EGD, Temperley I, Perembelon YFN, Scott J, et al. A gene for hereditary telangiectasia maps to chromosome 9q3. Nat Genet 1994; 6: 205-9.
6. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996; 13(2): 189-9.
7. Braverman IM, Key A, Jacobson BS. Ultrastucture and three dimensional organization of the telengiectases of hereditary hemorrhagic telengiectasia. J Invest Dermatol 1990; 95:422-7.
8. Jacobson BS. Hereditary Hemorrhagic Telangiectasia: a model for blood vessel growth and enlargement. Am J Pathol 2000; 156: 737-42.
9. Bourdeau A, Trop S, Yeung RSM, Mc Donald ML, Zuniga-Pflucker JC, Letarte M. Endoglin heterozygous mice show B and T cell defects. IVth HHT Scientific Conference Tenerife, Canary Islands, April 2001 (Abstract).
10. Cho SK, Bourdeau A, Letarte M, Zuniga-Pflucker JC. Expression and function of CD105 during the onset of hematopoiesis from F1K1 (+) precursors. Blood 2001; 98: 3635-42.
11. Amati L, Passeri ME, Resta F, Triggiani V, Jirillo E, Sabbà C. Ablation of T-Helper 1 cell derived cytokines and of monocyte-derived tumor necrosis factor-α in hereditary hemorrhagic teleangiectasia: immunological consequences and clinical considerations. Curr Pharm Design 2005; 11.
12. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJJ, et al. Diagnostic Criteria for Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber-Syndrome). Am J Med Genet 2000; 91:66-7.
13. Adams HP Jr, Subbiah B, Bosch EP. Neurologic aspects of HHT: report of two cases. Arch Neurol 1997; 34: 101-4.
14. Hewes RC, Auster M, White RI Jr. Cerebral embolism first manifestation of pulmonary arteriovenous malformation in patiens with HHT. Cardiovasc Intervent Radiol 1985; 8: 151-5.
15. el-Houcheimi I, Hardwidge C, Walter P, Jalaluddin M. Brain abscess and Hereditary Hemorrhagic Telangiectasia: a report of three cases. Br J Neurosurg 1998; 12 (1): 15-7.
16. Ishikawa S, Sawada K, Tanahashi Y, Tsuzuki J, Hattori M, Hayashi H, et al. A case of multiple small pulmonary arteriovenous fistulas associated with hepatic abscess. Kokyu To Junkan 1979; 27: 183-9.
17. Kawaguchi T, Fujita S, Yamada H, Nishida Y, Izawa I. Multiple cerebral and pulmonary arteriovenous malformations in association with brain and subcutaneous abscesses: a possible variant of hereditary hemorrhagic telangiectasia. Neurol Med Chir 1990; 30: 272-6.
18. Ishida T, Matsumura Y, Miyake A, Wazawa H, Tamada J. A case of multiple pulmonary arteriovenous fistulae associated with splenic abscess. Nihon Kyobu Shikkan Gakkai Zasshi 1991; 29: 482-6.
19. Duval X, Djendli S, Le Moing V, Longuet P, Barry B, Leport C, et al. Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorragic telangiectasia (Osler-Rendu-Weber-disease). Am J Med 2001; 110: 671-2.
20. Abdalla SA, Geistoff UW, Bonneau D, Plauchu H, Mc Donald J, Kennedy S, et al. Visceral manifestation in hereditary hemorrhagic telangiectasia type 2. J Med Genet 2003; 40: 494-502.
21. Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR, Letarte M. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol 2001; 158: 2011-20.
22. Turley JM, Falk LA, Ruscetti FW, Kasper JJ, Francomano T, Fu T, et al. Transforming Growth Factor beta 1 function in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Cell Growth Differ 1996; 7: 1535-44.
23. Lagraoui M, Gagnon L. Enhancement of human neutrophil survival and activation by TGF-beta 1. Cell Mol Biol 1997; 43: 313-8.
24. Schroeder K, Hertzog PJ, Ravasi T, Aume DA. Interferon-γ: an overview of signals, mechanism and functions. J Leukoc Biol, 2004; 75:163-189.
25. Roshdes E, Dimitriadou-Georgiadou A, Sein T, Kadiltsoglou I, Walsh TJ. Tumor necrosis factor alpha enhances antifungal activities of polimorphonuclear and mononuclear phagocytes against aspergillus fumigatus. Infect Immun 1998; 66: 5999-6003.
26. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-12.
27. Anderson HA, Shacter E. Natural anticoagulant proteins in the regulation of autoimmunity: potential role of protein S. Curr Pharm Des 2004; 10(8): 929-37.
28. Jain R, Danziger LH. The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Curr Pharm Des 2004; 10(25): 3045-53.
29. Sato Y. Modulation of PMN-endothelial cells interactions by cyclic nucleotides. Curr Pharm Des 2004; 10(2): 163-70.